Senior insider sale
KESTRA MEDICAL TECHNOLOGIES, LTD. — senior position signals high conviction
$143.8K
5.69K shares
What this filing means
HANLEY CONOR plans to sell 5.69K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. valued at approximately $143.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/8/2026ACC: 0001964306-26-000431
Director
Since Jun 2025
5.69K
Shares to sell
$143.8K
Approx. market value
5.69K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit awards
Granted as part of issuer equity compensation plan
9/4/2026
5.69KTotal acquired5.69K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/4/2026 | Vesting of restricted stock unit awards Granted as part of issuer equity compensation plan | 5.69K | — |
| Total | 5.69K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
5.69K
Market value
$143.8K
9/8/2026
Total
Units
5.69K
Value
$143.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/8/2026 | 5.69K | $143.8K | NASDAQ | Planned |
| Total | 5.69K | $143.8K | ||